Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:1484089.
doi: 10.1155/2016/1484089. Epub 2016 Feb 14.

Glucagonoma and Glucagonoma Syndrome: A Case Report with Review of Recent Advances in Management

Affiliations

Glucagonoma and Glucagonoma Syndrome: A Case Report with Review of Recent Advances in Management

Ashraf Al-Faouri et al. Case Rep Surg. 2016.

Abstract

The rarity of glucagonoma imposes a challenge with most patients being diagnosed after a long period of treatment for their skin rash (months-years). Awareness of physicians and dermatologists of the characteristic necrolytic migratory erythema often leads to early diagnosis. Early diagnosis of glucagonoma even in the presence of resectable liver metastases may allow curative resection. Herein, we present a typical case of glucagonoma treated at our center and review the literature pertinent to its management.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Necrolytic migratory erythema over the back with areas of healing and hyperpigmentation.
Figure 2
Figure 2
Glossitis.
Figure 3
Figure 3
Onychoschizia.
Figure 4
Figure 4
Hypervascular tumor in the tail of pancreas with metastases in segment V of the liver.
Figure 5
Figure 5
Glucagonoma in the tail of pancreas.

References

    1. Braverman I. M. Cutaneous manifestations of internal malignant tumors by Becker, Kahn and Rothman, June 1942. Archives of Dermatology. 1982;118(10):784–798. - PubMed
    1. Wei J., Lin S., Wang C., et al. Glucagonoma syndrome: a case report. Oncology Letters. 2015;10:1113–1116. doi: 10.3892/ol.2015.3275. - DOI - PMC - PubMed
    1. Wermers R. A., Fatourechi V., Wynne A. G., Kvols L. K., Lloyd R. V. The glucagonoma syndrome: clinical and pathologic features in 21 patients. Medicine. 1996;75(2):53–63. doi: 10.1097/00005792-199603000-00002. - DOI - PubMed
    1. Wu S. L., Bai J. G., Ma Q. Y., et al. Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor. World Journal of Surgical Oncology. 2014;12:220–222. doi: 10.1186/1477-7819-12-220. - DOI - PMC - PubMed
    1. Castro P. G., de León A. M., Trancón J. G., et al. Glucagonoma syndrome: a case report. Journal of Medical Case Reports. 2011;5:402–406. doi: 10.1186/1752-1947-5-402. - DOI - PMC - PubMed

LinkOut - more resources